IL319202A - Substrates for fermentation methods to create polysaccharides in bacterial cells - Google Patents

Substrates for fermentation methods to create polysaccharides in bacterial cells

Info

Publication number
IL319202A
IL319202A IL319202A IL31920225A IL319202A IL 319202 A IL319202 A IL 319202A IL 319202 A IL319202 A IL 319202A IL 31920225 A IL31920225 A IL 31920225A IL 319202 A IL319202 A IL 319202A
Authority
IL
Israel
Prior art keywords
medium
polysaccharide
concentration
vvh
perfusion
Prior art date
Application number
IL319202A
Other languages
English (en)
Hebrew (he)
Inventor
Gururao Desai Sunil
Allen Hanson Michael
R Lasko Daniel
Ellis LOMBERK Scott
Arnold Lotvin Jason
Kaushikbhai PATEL-BROWN Sujata
Sun Weiqiang
Anthony Tomasello Peter
Patrick Kinross Jonathan
Original Assignee
Pfizer
Gururao Desai Sunil
Allen Hanson Michael
R Lasko Daniel
Ellis LOMBERK Scott
Arnold Lotvin Jason
Sujata Kaushikbhai Patel Brown
Sun Weiqiang
Anthony Tomasello Peter
Patrick Kinross Jonathan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer, Gururao Desai Sunil, Allen Hanson Michael, R Lasko Daniel, Ellis LOMBERK Scott, Arnold Lotvin Jason, Sujata Kaushikbhai Patel Brown, Sun Weiqiang, Anthony Tomasello Peter, Patrick Kinross Jonathan filed Critical Pfizer
Publication of IL319202A publication Critical patent/IL319202A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/04Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46Streptococcus ; Enterococcus; Lactococcus
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL319202A 2015-11-17 2016-11-10 Substrates for fermentation methods to create polysaccharides in bacterial cells IL319202A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562256347P 2015-11-17 2015-11-17
US201662413051P 2016-10-26 2016-10-26
PCT/IB2016/056780 WO2017085602A1 (en) 2015-11-17 2016-11-10 Media and fermentation methods for producing polysaccharides in bacterial cell culture

Publications (1)

Publication Number Publication Date
IL319202A true IL319202A (en) 2025-04-01

Family

ID=57394621

Family Applications (2)

Application Number Title Priority Date Filing Date
IL319202A IL319202A (en) 2015-11-17 2016-11-10 Substrates for fermentation methods to create polysaccharides in bacterial cells
IL259404A IL259404B2 (en) 2015-11-17 2016-11-10 Media and fermentation methods for producing polysaccharides in bacterial cell culture

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL259404A IL259404B2 (en) 2015-11-17 2016-11-10 Media and fermentation methods for producing polysaccharides in bacterial cell culture

Country Status (13)

Country Link
US (2) US10947494B2 (enExample)
EP (1) EP3377613A1 (enExample)
JP (3) JP7311966B2 (enExample)
KR (1) KR102069988B1 (enExample)
CN (1) CN108473945A (enExample)
AU (1) AU2016357567B2 (enExample)
BR (1) BR112018008864A8 (enExample)
CA (2) CA3138763A1 (enExample)
HK (1) HK1259103A1 (enExample)
IL (2) IL319202A (enExample)
MX (2) MX385736B (enExample)
RU (2) RU2021135165A (enExample)
WO (1) WO2017085602A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112013027229B1 (pt) 2011-04-22 2020-10-27 Wyeth Llc polipeptídeo imunogênico isolado e seu uso, composição imunogênica e seu uso, célula recombinante ou progênie da mesma, e método de produção de uma toxina de clostridium difficile mutante
LT2837680T (lt) 2011-07-01 2020-07-10 Amgen Inc. Žinduolių ląstelių kultūra
BR122016023101B1 (pt) 2012-10-21 2022-03-22 Pfizer Inc Polipeptídeo, composição imunogênica que o compreende, bem como célula recombinante derivada de clostridium difficile
WO2018045286A1 (en) 2016-09-02 2018-03-08 Sanofi Pasteur, Inc. Neisseria meningitidis vaccine
EP3576784B1 (en) 2017-01-31 2025-09-24 Merck Sharp & Dohme LLC Methods for making polysaccharide-protein conjugates
MX2019009867A (es) 2017-02-24 2019-10-02 Merck Sharp & Dohme Inmunogenicidad mejorada de conjugados de polisacarido-proteina de streptococcus pneumoniae.
MX394768B (es) 2017-09-07 2025-03-21 Merck Sharp & Dohme Llc Polisacaridos neumococicos y su uso en conjugados de polisacarido inmunogenico con proteina.
WO2019050816A1 (en) 2017-09-07 2019-03-14 Merck Sharp & Dohme Corp. ANTI-PNEUMOCOCCAL POLYSACCHARIDES AND THEIR USE IN IMMUNOGENIC CONJUGATES POLYSACCHARIDE-PROTEIN CARRIER
MX2020005779A (es) 2017-12-06 2020-10-28 Merck Sharp & Dohme Composiciones que comprenden conjugados de polisacarido de streptococcus pneumoniae con proteina y metodos de uso de estos.
US20210252125A1 (en) 2018-04-30 2021-08-19 Merck Sharp & Dohme Corp. Methods for producing streptococcus pneumoniae capsular polysaccharide carrier protein conjugates
US11896656B2 (en) 2018-04-30 2024-02-13 Merck Sharp & Dohme Llc Methods for providing a homogenous solution of lyophilized mutant diptheria toxin in dimethylsulfoxide
EP3787674A4 (en) 2018-04-30 2022-01-26 Merck Sharp & Dohme Corp. PROCESS FOR THE PRODUCTION OF STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDE CAPSULAR PROTEIN CONJUGATES FROM LYOSPHERES
WO2020117949A1 (en) * 2018-12-06 2020-06-11 Inventprise, Llc Bacterial growth on non-animal derived media
EP3876953A4 (en) * 2018-12-11 2022-10-19 ERBI Biosystems, Inc. PROCESS FOR MANUFACTURING CELL-BASED PRODUCTS USING SMALL VOLUME PERFUSION PROCESSES
AU2019401535B2 (en) 2018-12-19 2023-12-14 Merck Sharp & Dohme Llc Compositions comprising Streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
CN111254103B (zh) * 2019-11-19 2023-06-02 河南省生物工程技术研究中心 一种非洲猪瘟基因工程疫苗高密度发酵补料培养基及发酵工艺
DK4138771T3 (da) * 2020-04-20 2024-05-27 Evonik Operations Gmbh Sammensætninger, som omfatter cys-peptidr
CN114015622A (zh) * 2021-12-14 2022-02-08 塔里木大学 无乳链球菌培养基及其制备方法
JP2025501499A (ja) * 2022-01-05 2025-01-22 ノルドマルク ファーマ ゲーエムベーハー Hathewaya histolytica(またはclostridium histolyticum)を増殖させるための、および1種または複数のプロテアーゼの産生のための培養培地
CN114181872B (zh) * 2022-01-07 2023-11-24 北京大北农科技集团股份有限公司 一种屎肠球菌高密度发酵培养方法
KR102866798B1 (ko) * 2022-12-27 2025-10-01 (주)진성유니텍 살모넬라균 증균을 위한 최소배지 및 이를 이용한 살모넬라균 증균방법
KR102864280B1 (ko) * 2022-12-27 2025-09-26 (주)진성유니텍 포도상구균 증균을 위한 최소배지 및 이를 이용한 포도상구균 증균방법
CN117821342B (zh) * 2024-02-29 2024-06-04 北京民海生物科技有限公司 一种14型肺炎链球菌的发酵方法
KR102894728B1 (ko) 2024-11-27 2025-12-08 한국콜마주식회사 피지 생성 억제 효능, 모공 개선 효능 및 피부 장벽 강화 효능이 우수한 흑효모 발효물 및 이의 제조방법

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5801054A (en) * 1996-09-19 1998-09-01 The United States Of America As Represented By The Secretary Of The Air Force Cell culture vessel with self-maintained atmosphere
EP1849860B1 (en) * 1997-05-28 2010-11-17 Novartis Vaccines and Diagnostics S.r.l. Process for preparing an immunogenic factor of Corynebacterium diphtheriae using a culture medium with yeast extract as aminoacid source and no protein complexes of animal origin
US7115385B2 (en) 2001-08-02 2006-10-03 North Carolina State University Media and methods for cultivation of microorganisms
US7294484B2 (en) 2004-08-27 2007-11-13 Wyeth Research Ireland Limited Production of polypeptides
US7472101B2 (en) 2005-07-12 2008-12-30 Tibco Software Inc. Inferential state machines
GB0522303D0 (en) 2005-11-01 2005-12-07 Chiron Srl Culture method
US7491517B2 (en) 2006-07-19 2009-02-17 Jeeri R Reddy Method of producing meningococcal meningitis vaccine for Neisseria meningitidis serotypes A,C,Y, and W-135
TW200827445A (en) 2006-11-08 2008-07-01 Wyeth Corp Rationally designed media for cell culture
GB0818453D0 (en) * 2008-10-08 2008-11-12 Novartis Ag Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom
WO2011151841A1 (en) * 2010-05-31 2011-12-08 Panacea Biotec Limited Fermentation process for streptococcus pneumoniae
WO2012155295A1 (zh) * 2011-05-17 2012-11-22 中国食品发酵工业研究院 一种工业化生产玉米降压活性肽的方法
EP2791317B1 (en) * 2011-12-15 2017-02-01 Serum Institute Of India Private Limited A novel process of cultivating bacteria for yield improvement of capsular polyoses
EP2647715A1 (en) * 2012-04-03 2013-10-09 Nomad Bioscience GmbH Agrobacterium for transient transfection of whole plants
GB201211256D0 (en) 2012-06-25 2012-08-08 Glaxosmithkline Biolog Sa Fermentation process
MX364644B (es) * 2012-11-21 2019-05-03 Serum Inst India Ltd Produccion de altos rendimientos de polisacaridos bacteriales.

Also Published As

Publication number Publication date
RU2761633C2 (ru) 2021-12-13
IL259404A (en) 2018-07-31
CA3005308C (en) 2022-01-04
MX2018006063A (es) 2018-09-17
RU2021135165A (ru) 2021-12-29
CA3138763A1 (en) 2017-05-26
HK1259103A1 (zh) 2019-11-22
KR20180073699A (ko) 2018-07-02
JP2022017529A (ja) 2022-01-25
US20210180008A1 (en) 2021-06-17
RU2018118035A3 (enExample) 2019-12-18
IL259404B1 (en) 2025-04-01
JP7311966B2 (ja) 2023-07-20
AU2016357567B2 (en) 2020-05-07
US10947494B2 (en) 2021-03-16
CA3005308A1 (en) 2017-05-26
JP2024037949A (ja) 2024-03-19
CN108473945A (zh) 2018-08-31
WO2017085602A1 (en) 2017-05-26
KR102069988B1 (ko) 2020-01-23
RU2018118035A (ru) 2019-12-18
AU2016357567A1 (en) 2018-05-17
BR112018008864A8 (pt) 2019-02-26
JP2018533366A (ja) 2018-11-15
BR112018008864A2 (pt) 2018-11-06
US20190292513A1 (en) 2019-09-26
MX2021010518A (es) 2021-10-01
MX385736B (es) 2025-03-18
IL259404B2 (en) 2025-08-01
EP3377613A1 (en) 2018-09-26

Similar Documents

Publication Publication Date Title
AU2016357567B2 (en) Media and fermentation methods for producing polysaccharides in bacterial cell culture
CN104936615B (zh) 高产量的细菌多糖的制备
US20080274515A1 (en) Animal component free meningococcal polysaccharide fermentation and seedbank development
RU2644246C2 (ru) Способ получения капсулярного полисахарида Haemophilus influenzae типа b, применение капсулярного полисахарида и способ получения вакцинной композиции
JP2023139253A (ja) 難培養性嫌気性微生物の高収率培養のための培地サプリメント及びそれを含む培地組成物
Wang et al. Actinoplanes utahensis ZJB-08196 fed-batch fermentation at elevated osmolality for enhancing acarbose production
CN115975909A (zh) 适用于猫肾细胞f81高密度培养的无血清培养基
WO2025219908A2 (en) Media and fermentation methods for polysaccharide production in bacterial cell culture
Hohl et al. NUTRITION OF CELLULAR SLIME MOLDS III: Specific Growth Requirements of Polysphondylium pallidum
KR20240173904A (ko) 아커만시아속 미생물의 고수율 생산용 배지 조성물, 그를 이용한 배양방법 및 동결건조 방법
SU615130A1 (ru) Способ получени 5- инозиновой кислоты
Salimova et al. PECULIARITIES OF CULTIVATION OF HAEMOPHILUS INFLUENZAE TYPE B STRAINS-PRODUCERS OF POLYRIBOSYLRIBITOL PHOSPHATE-THE MAIN COMPONENT OF POLYSACCHARIDE VACCINES
JPS6324977B2 (enExample)